Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone Ophthalmic Ointment in Allergic Conjunctivitis
NCT01860664Phase 2Terminated
- Sponsor
- Koffler Vision Group
- Start
- May 2013
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Alkindi Sprinkle in allergic conjunctivitis (AC), sponsored by Koffler Vision Group. Started May 2013; status: terminated.
02
Drugs
Alkindi Sprinkle
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01860664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860664.